Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 62436

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 05, 2012
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Apotex Corp.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Meloxicam Tablets, USP, 15 mg, Rx Only, 100 Tablets per Bottle, Manufactured by: Strides Acrolab Ltd., Bangalore-560 076, India, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-3579-1.

D-1443-2012
Recall number
D-1443-2012
Initiated
April 05, 2012
Classification
Class II
Status
Terminated
Recalling firm
Apotex Corp.
Quantity
1,749 Bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.

Code information

Lot: 7212558, Exp 12/12.

Distribution pattern

Nationwide